TAAV Biomanufacturing Solutions, an independently operated wholly owned subsidiary of Asklepios BioPharmaceutical (AskBio) and a member of the Bayer worldwide group of companies, has appointed Dolores Baksh as CEO. TAAV is a synthetic DNA manufacturer. Baksh brings a 20-year track record of biotechnology R&D, product development and cGMP manufacturing leadership to the firm. She joins…